<unk>  is a calcitonin-gene related peptide antagonist that is FDA approved for the preventive treatment of of migraine and the treatment of episodic cluster headache.   Common adverse reactions include injection site reactions.
Galcanezumab-gnlm
Fremanezumab-vfrm
Tisotumab vedotin-tftv
Cemiplimab-rwlc
Ustekinumab
Lanadelumab
Ofatumumab
Raxibacumab